Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calidi Biotherapeutics (CLDI) Beginning Cash Balance (2025)

Calidi Biotherapeutics' quarterly Beginning Cash Balance came in at $375000.0 in Q3 2025, little changed quarter-over-quarter from $375000.0 in Q2 2025.

Calidi Biotherapeutics has reported Beginning Cash Balance for 1 years, with the latest figure at $375000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Beginning Cash Balance changed N/A year-over-year to $375000.0; the trailing twelve-month figure through Dec 2025 stood at $2.0 million (changed N/A YoY), and the FY2025 full-year result was $2.0 million, changed N/A from the prior year.
  • Beginning Cash Balance for Q3 2025 stood at $375000.0, roughly flat from $375000.0 in the prior quarter.
  • The five-year high for Beginning Cash Balance was $1.2 million in Q1 2025, with the low at $375000.0 in Q2 2025.

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 375,000.00
Sep 30, 2025 375,000.00
Jun 30, 2025 375,000.00
Jun 30, 2025 375,000.00
Mar 31, 2025 1.25 Mn
Mar 31, 2025 1.25 Mn